251 related articles for article (PubMed ID: 3484992)
1. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
Pranzatelli MR; Snodgrass SR
Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
[TBL] [Abstract][Full Text] [Related]
3. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
Pranzatelli MR; Snodgrass SR
Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
[TBL] [Abstract][Full Text] [Related]
4. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
Eide PK; Hole K; Berge OG; Broch OJ
Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
[TBL] [Abstract][Full Text] [Related]
5. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
6. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
7. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
Pranzatelli MR; Snodgrass SR
Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
[TBL] [Abstract][Full Text] [Related]
8. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
9. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
Butler PD; Pranzatelli MR; Barkai AI
Brain Res Bull; 1990 Jan; 24(1):125-9. PubMed ID: 2155684
[TBL] [Abstract][Full Text] [Related]
10. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
Chance WT; von Meyenfeldt M; Fischer JE
Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
[TBL] [Abstract][Full Text] [Related]
11. Effects of p-chloroamphetamine and 5,7-dihydroxytryptamine on the sexual behavior of gonadectomized male and female rats.
Södersten P; Berge OG; Hole K
Pharmacol Biochem Behav; 1978 Oct; 9(4):499-508. PubMed ID: 733836
[TBL] [Abstract][Full Text] [Related]
12. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
Pranzatelli MR; Eng B
Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Lorens SA; Hata N; Cabrera T; Hamilton ME
NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
[No Abstract] [Full Text] [Related]
14. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin, p-chloroamphetamine, and tryptamine in mice.
Orikasa S; Sloley BD
Psychopharmacology (Berl); 1988; 95(1):124-31. PubMed ID: 3133691
[TBL] [Abstract][Full Text] [Related]
15. Endogenous levels of serotonin and 5-hydroxyindoleacetic acid in specific areas of the pigeon CNS: effects of serotonin neurotoxins.
Alesci R; Bagnoli P
Brain Res; 1988 May; 450(1-2):259-71. PubMed ID: 2456822
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
17. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
[TBL] [Abstract][Full Text] [Related]
18. Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine.
Commins DL; Axt KJ; Vosmer G; Seiden LS
Brain Res; 1987 Sep; 419(1-2):253-61. PubMed ID: 2445423
[TBL] [Abstract][Full Text] [Related]
19. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
Carlton J; Rowland N
Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
